Pfizer Inc. has secured an exclusive global licensing agreement with 3SBio, Inc., a leading Chinese biopharma, for SSGJ-707.

The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially ...

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...

Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics ... If those results are positive the partners have said they could file for approval in the ...

The growing demand for Foley catheters is driven by several important factors. Firstly, the rising global aging population is contributing to a highe ...

The Business Research Company The Business Research Company's Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – M ...

While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

Kicking off this week in Chicago, this year’s American Association for Cancer Research conference will feature presentations ...

Ralph Hughes joins Faron to strengthen Commercial Strategy, Business Development and Market Assessment function TURKU, FI / ACCESS Newswire / May 21, 2025 /Faron Pharmaceuticals Ltd. (AIM:FARN)(First ...

The Dementia Discovery Fund ("DDF"), managed by SV Health Investors, today announced the final closing of its second fund, DDF-2, with $269m in commitments. DDF is the world's largest family of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...